売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2025/1 |
317,044 |
74.5% |
| 2024/1 |
318,989 |
76.3% |
| 2023/1 |
308,645 |
76.3% |
| 2022/1 |
257,961 |
74.0% |
| 2021/1 |
210,180 |
73.0% |
| 2020/1 |
173,395 |
67.7% |
| 2019/1 |
142,464 |
65.2% |
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2025/1 |
-59,282 |
-18.7% |
| 2024/1 |
-54,881 |
-17.2% |
| 2023/1 |
-88,873 |
-28.8% |
| 2022/1 |
-88,470 |
-34.3% |
| 2021/1 |
-73,085 |
-34.8% |
| 2020/1 |
-115,267 |
-66.5% |
| 2019/1 |
-144,087 |
-101.1% |
|
（単位：千ドル）
|
2019/1
|
2020/1
|
2021/1
|
2022/1
|
2023/1
|
2024/1
|
2025/1
|
|
売上高
|
142,464
|
173,395
|
210,180
|
257,961
|
308,645
|
318,989
|
317,044
|
|
売上成長率（％）
|
-
|
|
21.2
|
22.7
|
19.7
|
3.4
|
-0.6
|
|
売上原価
|
49,554
|
55,930
|
56,748
|
67,146
|
73,078
|
75,470
|
80,993
|
|
売上総利益
|
92,910
|
117,465
|
153,432
|
190,815
|
235,567
|
243,519
|
236,051
|
|
売上総利益率（％）
|
|
|
73.0
|
74.0
|
76.3
|
76.3
|
74.5
|
|
研究開発費
|
75,740
|
69,224
|
66,474
|
81,027
|
95,093
|
85,049
|
87,899
|
|
営業費用
|
236,997
|
232,732
|
226,517
|
279,285
|
324,440
|
298,400
|
295,333
|
|
営業利益
|
-144,087
|
-115,267
|
-73,085
|
-88,470
|
-88,873
|
-54,881
|
-59,282
|
|
営業利益率 (%)
|
|
|
-34.8
|
-34.3
|
-28.8
|
-17.2
|
-18.7
|
|
経常（税引前）利益
|
-153,061
|
-124,902
|
-84,225
|
-102,572
|
-104,372
|
-74,312
|
-80,725
|
|
経常（税引前）利益率（％）
|
-107.4
|
-72.0
|
-40.1
|
-39.8
|
-33.8
|
-23.3
|
-25.5
|
|
法人税等合計
|
1,248
|
754
|
409
|
-461
|
1,179
|
1,257
|
1,210
|
|
実効税率（％）
|
|
|
-0.5
|
0.4
|
-1.1
|
-1.7
|
-1.5
|
|
純利益
|
-154,309
|
-125,656
|
-84,634
|
-102,111
|
-105,551
|
-75,569
|
-81,935
|
|
純利益率（％）
|
|
|
-40.3
|
-39.6
|
-34.2
|
-23.7
|
-25.8
|
|
一株あたり利益
|
-
|
-
|
-
|
-3.19
|
-3.1
|
-2.1
|
-2.13
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-3.19
|
-3.1
|
-2.1
|
-2.13
|
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-50,046
|
|
EBITDAマージン（％）
|
-
|
-
|
-
|
-
|
-
|
-
|
-15.8
|